Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for MRVL on May 31, 2024 07:36AM ET. The previous analyst recommendation was Outperform.MRVL was trading at $76.85 at issue of the analyst...

May 31, 2024   MRVL 2.80%

Oppenheimer analyst issues OUTPERFORM recommendation for ASAN on May 31, 2024 07:36AM ET. The previous analyst recommendation was Outperform.ASAN was trading at $13.13 at issue of the analyst...

May 31, 2024   ASAN -0.45%

Oppenheimer analyst issues OUTPERFORM recommendation for MDB on May 31, 2024 07:36AM ET. The previous analyst recommendation was Outperform.MDB was trading at $310 at issue of the analyst...

May 31, 2024   MDB -0.23%

Piper Sandler analyst issues OVERWEIGHT recommendation for ZBH on May 31, 2024 07:29AM ET. The previous analyst recommendation was Overweight.ZBH was trading at $114.44 at issue of the...

May 31, 2024   ZBH 0.43%

Oppenheimer analyst issues OUTPERFORM recommendation for XYL on May 31, 2024 07:36AM ET. The previous analyst recommendation was Outperform.XYL was trading at $139.4 at issue of the analyst...

May 31, 2024   XYL -0.87%

Oppenheimer analyst issues OUTPERFORM recommendation for ZS on May 31, 2024 07:36AM ET. The previous analyst recommendation was Outperform.ZS was trading at $156.65 at issue of the analyst...

May 31, 2024   ZS -0.39%

Piper Sandler analyst issues OVERWEIGHT recommendation for COO on May 31, 2024 07:38AM ET. The previous analyst recommendation was Overweight.COO was trading at $90.23 at issue of the...

May 31, 2024   COO -0.43%

Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on May 31, 2024 07:40AM ET. The previous analyst recommendation was Overweight.ARCT was trading at $38.48 at issue of the...

May 31, 2024   ARCT -8.27%

Cowen & Co. analyst issues BUY recommendation for NTAP on May 31, 2024 07:39AM ET. The previous analyst recommendation was Buy.NTAP was trading at $116.5 at issue of...

May 31, 2024   NTAP 0.03%

Piper Sandler analyst issues OVERWEIGHT recommendation for LXRX on May 31, 2024 07:39AM ET. The previous analyst recommendation was Overweight.LXRX was trading at $1.7 at issue of the...

May 31, 2024   LXRX -2.18%